K. Barber

Ustekinumab for the treatment of moderate‐to‐severe plaque psoriasis in paediatric patients (≥ 6 to &lt; 12 years of age): efficacy, safety, pharmacokinetic and biomarker results from the open‐label <scp>CADMUS</scp> Jr study

Sandra Philipp, Alan Menter, Arjen Nikkels et al. · British Journal of Dermatology · 2020 · 77 citations · Full text

Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trial

Donald Y.M. Leung, Jon M. Hanifin, David M. Pariser et al. · British Journal of Dermatology · 2009 · 49 citations

Apremilast for the treatment of moderate‐to‐severe palmoplantar psoriasis: results from a double‐blind, placebo‐controlled, randomized study

Robert Bissonnette, Richard P. Haydey, L. Rosoph et al. · Journal of the European Academy of Dermatology and Venereology · 2017 · 47 citations

A comparison of prostate knowledge of African-American and Caucasian men: changes from prescreening baseline to postintervention.

R. Roderic Abbott, D. Kay Taylor, K. Barber · PubMed · 1998 · 46 citations

A Randomized, blinded assessor study to Evaluate the efFIcacy and safety of etanercept 50 mg once weekly plus as Needed topical agent vs. Etanercept 50 mg twice weekly in patients with moderate to severe plaque psoriasis (<scp>REFINE</scp>)

Kim Papp, K. Barber, Robert Bissonnette et al. · Journal of the European Academy of Dermatology and Venereology · 2014 · 14 citations · Full text